🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-525085-29-00
Completed Phase I

A first study in healthy volunteers to examine the safety and tolerability of convalescent plasma given through the nose,  as well as the duration of its presence in the nose

2025-525085-29-00 · tracked via the Priya Life Science EU tracker
Sponsor
Rode Kruis-Vlaanderen
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Respiratory Tract Diseases
Decision date
18/06/2026
Enrollment target
104
Sites
Belgium

Condition studied

Healthy volunteers

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-525085-29-00 on CTIS ↗ ← All trials in the EU